PACB

PACB

USD

Pacific Biosciences of California Inc. Common Stock

$1.760+0.020 (1.149%)

Reaalajas hind

Healthcare
Meditsiiniseadmed
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$1.740

Kõrge

$1.790

Madal

$1.630

Maht

10.33M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

531.4M

Tööstusharu

Meditsiiniseadmed

Riik

United States

Kauplemisstatistika

Keskmine maht

8.24M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $0.85Praegune $1.760Kõrge $2.66

Seotud uudised

Analyst Upgrades

Stephens & Co. Maintains Overweight on Pacific Biosciences, Raises Price Target to $2

Stephens & Co. analyst Mason Carrico maintains Pacific Biosciences with a Overweight and raises the price target from $1.8 to $2.

Vaata rohkem
Stephens & Co. Maintains Overweight on Pacific Biosciences, Raises Price Target to $2
GlobeNewswire

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced that, through its long-standing partnership with Berry

Vaata rohkem
PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China
GlobeNewswire

PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025

MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wednesday, November 5,

Vaata rohkem
PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025